Nucleoside reverse transcriptase inhibitors (NRTIs)
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
| Drug Name |
Reviews | Avg. Ratings |
|
|---|---|---|---|
| telbivudine systemic (Pro, More...) |
0 Review(s) | Rate It! | 10 |
| abacavir systemic (Pro, More...) |
0 Review(s) | Rate It! | 8.0 |
| tenofovir systemic (Pro, More...) |
0 Review(s) | Rate It! | 8.0 |
| lamivudine systemic (Pro, More...) |
0 Review(s) | Rate It! | 4.0 |
| stavudine systemic (Pro, More...) |
0 Review(s) | Rate It! | 1.0 |
| zidovudine systemic (Pro, More...) |
0 Review(s) | Rate It! | 1.0 |
| adefovir systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| didanosine systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| emtricitabine systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| entecavir systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| zalcitabine systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
See also
Medical Conditions associated with nucleoside reverse transcriptase inhibitors (NRTIs):

